RAPT Therapeutics (RAPT) Current Leases (2022 - 2024)
Historic Current Leases for Therapeutics (RAPT) over the last 3 years, with Q3 2024 value amounting to $2.5 million.
- Therapeutics' Current Leases rose 556.49% to $2.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.5 million, marking a year-over-year increase of 556.49%. This contributed to the annual value of $2.4 million for FY2023, which is 1275.91% up from last year.
- Therapeutics' Current Leases amounted to $2.5 million in Q3 2024, which was up 556.49% from $2.6 million recorded in Q2 2024.
- Therapeutics' 5-year Current Leases high stood at $2.6 million for Q2 2024, and its period low was $1.5 million during Q1 2022.
- In the last 3 years, Therapeutics' Current Leases had a median value of $2.3 million in 2023 and averaged $2.2 million.
- In the last 5 years, Therapeutics' Current Leases skyrocketed by 5522.29% in 2023 and then surged by 556.49% in 2024.
- Therapeutics' Current Leases (Quarter) stood at $2.2 million in 2022, then grew by 12.76% to $2.4 million in 2023, then increased by 3.06% to $2.5 million in 2024.
- Its Current Leases was $2.5 million in Q3 2024, compared to $2.6 million in Q2 2024 and $2.5 million in Q1 2024.